TY - JOUR AU - Prentice, RE AU - Tjandra, D AU - Garg, M AU - Lubel, JS AU - Fourlanos, S AU - Johnson, D AU - Al-Ani, A AU - Christensen, B Y2 - 2020/12/16 Y1 - 2020/10 SN - 0269-2813 UR - http://hdl.handle.net/11343/254607 LA - eng T1 - Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19. DO - 10.1111/apt.16063 IS - Alimentary Pharmacology and Therapeutics VL - 52 IS - 8 SP - 1422-1423 ER -